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~,bstract Exposure of rat glomerular mesangial cells and 
primary cultures of bovine glomerular endothelial cells to 
compounds releasing nitric oxide (NO), including MAHMA- 
NONOate, S-nitrosoglutathione, and spermine-NO, results in a 
time- and concentration-dependent activation of stress-activated 
protein kinases (SAPK) as measured by the phosphorylation of 
c-Jun in a solid phase kinase assay. Dibutyryl cGMP had no 
effect on SAPK activity. Pretreatment of the cells with the 
tyrosine kinase inhibitor genistein strongly attenuated NO- 
induced c-Jun phosphorylation. Furthermore, N-acetylcysteine 
markedly reduced the activation of SAPK in response to NO. 
rhese studies identify SAPK as a target for NO which may be 
critical for the NO-induced apoptosis of glomerular mesangial 
and endothelial cells. 
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I. Introduction 
Nitric oxide (NO) is a short-lived, free-radical gas synthe- 
sized by NO synthase and mediates cell-cell communication 
i.hroughout he body. Produced in appropriate amounts by 
~ndothelial cells, neurons or macrophages, it contributes to 
blood pressure regulation, neuronal communication and im- 
~nune defence. On the other hand, excessive and uncontrolled 
~roduction of NO is associated with severe diseases like septic 
~hock, stroke, neurodegeneration, diabetes mellitus, arthritis 
and other forms of acute and chronic inflammation [1-3]. 
Mesangial cells orchestrate inflammatory processes in the re- 
nal glornerulus by increased mediator production, increased 
matrix production, and increased mesangial cell proliferation 
:~14,5]. An important and highly versatile member of this or- 
chestra of inflammatory mediators produced by mesangial 
cells is NO [5,6]. Mesangial cells exposed to inflammatory 
cytokines like interleukin l I] or tumour necrosis factor c~ ex- 
press the inducible NO synthase and produce high concentra- 
tions of NO [7-9] which may contribute to certain forms of 
glomerulonephritis [10,11]. We have recently reported that 
glomerular mesangial cells and endothelial cells are not only 
production sites of  but are also themselves targets for NO and 
undergo apoptotic cell death upon exposure to high concen- 
trations of NO. NO generated from different NO-releasing 
compounds as well as NO-saturated solution induced apop- 
tosis in both cell types as demonstrated by intranucleosomal 
DNA fragmentation, enrichment of cytosolic DNA/histone 
complexes, an increasing number of fragmented DNA ends 
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and typical nuclear chromatin condensation [12]. Apoptosis 
is a controlled biological strategy to remove unwanted cells 
from a given tissue and thus is involved in physiological and 
pathophysiological processes [13,14]. Recently, it has been re- 
ported that a cascade of the mitogen-activated protein kinase 
family, the stress-activated protein kinase (SAPK) module, is 
required for induction of apoptosis [15,1611. We therefore were 
interested to investigate whether NO is able to trigger this 
signalling pathway in glomerular mesangial cells and endothe- 
lial cells. 
2. Materials and methods 
2.1. Cell culture 
Renal glomeruli from male Sprague-Dawley rats or from female 
Wistar rats (8~100 g body wt) were isolated under sterile conditions 
by a sieving technique, and glomerular cells were cultured as described 
previously [17]. In a second step, single cells were cloned by limited 
dilution in 96-microwell plates to obtain pure cultures of epithelial 
cells and mesangial cells [17]. Cells were identified as mesangial cells 
by (a) their typical stellate morphology; (b) positive staining for the 
intermediate filaments desmin and vimentin, which is considered to be 
specific for myogenic ells; (c) positive staining for Thy 1.1 antigen; 
(d) negative staining for factor VIII-related antigen and cytokeratin, 
excluding endothelial and epithelial contamination, respectively; and 
(e) generation of inositol trisphosphate upon activation of angiotensin 
II AT1 receptors was used as a functional criterion for characterizing 
the cloned cell line. For the experiments passages 8 15 of mesangial 
cells were used. Calf kidneys were obtained from a local slaughter- 
house and were used to obtain glomerular endothelial cell cultures by 
a method previously described by Ballermann [18] and modified by 
Briner and Kern [19]. Individual clones of endothelial cells were char- 
acterized by positive staining for factor VIII-related antigen and uni- 
form uptake of fluorescent acetylated low-density lipoproteins. Nega- 
tive staining for smooth muscle actin and cytokeratin excluded 
mesangial cell and epithelial cell contaminations. Cells were utilized 
at passages 5 11. 
2.2. c-Jun kinase assay 
Quiescent mesangial cells in 60-mm diameter dishes were stimulated 
as indicated. To stop the reaction, the cells were washed with ice-cold 
PBS and scraped into 0.5 ml of TLB buffer (20 mM Tris, pH 7.4, 137 
mM NaCI, 2 mM EDTA, 1% Triton X-100, 1 mM sodium vanadate, 
2 mM sodium pyrophosphate, 10% glycerol, I mM PMSF, 10 pg/ml 
leupeptin, 25 mM [3-glycerophosphate). Cells were then homogenized 
by passes through a 26 G needle, centrifuged for 5 rain at 14000Xg at 
4°C and 200 lag of protein from the supernatant was taken for the Jun 
kinase assay. The solid-phase Jun kinase assay was performed as 
described [20] using a glutathione S-transferase (GST)-c-Jun (5-89) 
fusion protein coupled to glutathione-Sepharose beads as substrate. 
In brief, 10 lag of GST-c-Jun was coupled to 10 lal of glutathione- 
Sepharose in 0.5 ml of TLB buffer for 30 min at 4°C. The beads were 
then centrifuged for 20 s at 14000Xg, washed twice with TLB buffer 
and incubated for 2 h at 4°C with cell extracts in TLB buffer contain- 
ing 200 lag of protein. Thereafter, the complexes were washed twice 
with TLB buffer and once with 20 mM HEPES, pH 7.4, 20 mM 
MgCI2 before the kinase reaction was started by addition of 30 lal 
of kinase buffer (20 mM HEPES, pH 7.4, 20 mM MgCI2, 2 mM DTT, 
20 mM ~-glycerophosphate, 0.1 mM Na:~VO4, 20 mM p-nitrophenyl- 
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phosphate, 10 ~M ATP and 2 ktCi [7-a2p]ATP) to the complexes and 
incubated for 20 min at 30°C. To stop the reaction, 30 gl of 
2 x Laemmli sample buffer was added and the samples were heated 
for 5 rain at 95°C. Proteins were separated by SDS-PAGE (13% 
acrylamide gel) and phosphorylated GST-c-Jun was detected by auto- 
radiography and quantitated by a phosphorimager (Molecular Dy- 
namics). 
2.3. Chemicals" 
( Z)- 1 - { N- Methyl- N-[ 6-( N-methylammoniohex yl )amino) } diazen- 1- 
ium 1,2-diolate (MAHMA-NONOate), S-nitrosoglutathione (GSNO) 
and (Z)- 1- { N-[3-aminopropyl]-N-[4-(3-aminopropylammonio)butyl] 
amino}diazen-l-ium 1,2-diolate (spermine-NO) were from Alexis 
Corp., L/iufelfingen, Switzerland; [7-32P]ATP (spec. act. > 5000 Ci/ 
mmol), anti-rabbit horseradish peroxidase-linked IgG and hyperfilm 
were from Amersham; glutathione-Sepharose 4B was from Pharmacia 
Fine Chemicals, Uppsala, Sweden; GST-c-Jun (5-89) was produced 
by Ciba-Geigy Ltd., Basel, Switzerland; all cell culture nutrients were 
from Gibco-BRL, Basel, Switzerland; all other chemicals were from 
Fluka, Buchs, Switzerland. 
3. Results 
Western blot analysis of mesangial cell lysates with poly- 
clonal antisera specific for SAPK isoforms demonstrated that 
SAPKa and -7, but not SAPK-13, are expressed in mesangial 
cells (Huwiler et al., manuscript submitted). We have used a 
solid-phase kinase assay with c-Jun (5-89) coupled to glu- 
tathione S-transferase asa substrate that binds all SAPK iso- 
forms and after precipitation with glutathione-Sepharose the 
N-terminal domain of c-Jun is phosphorylated by activated 
A MAHMA-NO 
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B MAHMA-NO 
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¢= GST-Jun 
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¢= GST- Jun 
Fig. 1. Time course of MAHMA-NONOate- and spermine-NO- 
stimulated SAPK activity in glomerular endothelial cells (A) and 
mesangial cells (B,C). Quiescent endothelial cells (A) or mesangial 
cells (B,C) were treated for the indicated time periods with vehicle 
(Co), MAHMA-NONOate (1 mM) or spermine-NO (1mM), as in- 
dicated. Thereafter, cells were harvested and SAPK activity was 
measured as described in Section 2. Similar esults were obtained in 
three independent experiments. 
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Fig. 2. Concentration dependency of MAHMA-NONOate-induced 
SAPK activity in glomerular endothelial cells and mesangial cells. 
Quiescent endothelial or mesangial cells were treated with the indi- 
cated concentrations of MAHMA-NONOate for 60 or 30 min, re- 
spectively. Cells were harvested and 200 gg of cell protein was taken 
for SAPK activity measurement as described in Section 2. Results 
are means of three independent experiments; the S.D. ranges from 
12 to 80%. 
SAPKs [20]. The data in Fig. 1A show that MAHMA-NON- 
Oate augments SAPK activity in glomerular endothelial cells 
within 1~20 min and further increases SAPK activity, with a 
maximal 10-fold stimulation at 60 min, the latest time point 
examined. Whereas the response to MAHMA-NONOate is 
sustained over at least 60 min in endothelial cells the response 
of mesangial cells is more transient as shown in Fig. lB. 
Maximal SAPK activity in mesangial cells is observed 30 
min after addition of MAHMA-NONOate and then declines 
again (Fig. 1B). MAHMA-NONOate is an NO donor that 
releases NO with a half-life of approx. 1-2 min under neutral 
pH conditions at 37°C [21]. This massive release of NO acti- 
vates SAPK activity with a potency comparable to that of 
anisomycin (50 ng/ml) (Fig. 1A), a classical stress-activator 
of the SAPK pathway [22]. Spermine-NO is another NONO- 
ate that displays a much slower release of NO with a half-life 
of approx. 10 90 min [21]. When compared to MAHMA- 
NONOate, exposure of mesangial cells to spermine-NO re- 
sults in weak stimulation of SAPK-activity which is maximal 
after 10 min and back to control evels after 30 rain (Fig. 1B). 
Furthermore, a third NO donor, S-nitrosoglutathione 
(GSNO), induced c-Jun phosphorylation i glomerular en- 
dothelial and mesangial cells (data not shown) thus confirm- 
ing that NO is able to the activate SAPK pathway in both cell 
types. Fig. 2 shows the concentration dependency of SAPK 
activation by MAHMA-NONOate in glomerular endothelial 
and mesangial cells. The addition of dibutyryl cGMP (0.5 
raM) to the culture medium did not induce any SAPK activa- 
tion (data not shown), thus excluding cGMP as a possible 
mediator of NO-induced SAPK stimulation. 
In order to study the possible mechanisms controlling the 
activation of SAPKs by NO in mesangial and endothelial 
cells, we used a specific inhibitor of protein tyrosine kinases, 
genistein, which is an isoflavone compound from fermentation 
broth of Pseudomonas pp. [23]. As shown in Fig. 3, genistein 
markedly reduces MAHMA-NONOate-induced SAPK acti- 
vation in endothelial and mesangial cells, thus suggesting 
that tyrosine phosphorylation is likely associated with the 
activation of the SAPK pathway by NO. In a subsequent 
step, we evaluated the effect of the free radical scavenger 
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aad antioxidant N-acetylcysteine on NO-stimulated c-Jun 
phosphorylation. N-acetylcysteine has been reported to block 
S~PK and nuclear factor ~B activation in response to UV 
light and other cellular stresses [24,25]. Coincubation of me- 
sangial or endothelial cells with MAHMA-NONOate and 
]X-acetylcysteine results in a strong inhibition of c-Jun phos- 
phorylation (Fig. 3). N-acetylcysteine itself had no significant 
elect on SAPK activity (data not shown). These data empha- 
sze the role of redox regulation in SAPK activation by NO. 
It has recently been proposed that stimulation of the SAPK 
tathway contributes to cell death [15,16]. As shown in Fig. 4 
s:~ermine-NO and MAHMA-NONOate cause a marked in- 
"ease in glomerular endothelial cell and mesangial cell apop- 
I )sis as measured by an ELISA based on the detection of 
~,tosolic histone/DNA complexes. Coincubation with N-ace- 
1 Acysteine and genistein inhibited NO-induced apoptosis in 
1 oth cell types (Fig. 4). 
a. Discussion 
The function of the mitogen-activated protein kinase cas- 
cade, also known as the extracellular signal-regulated protein 
inase pathway, is to convert extracellular signals to intracel- 
i~lar mediators that regulate metabolism, secretion, gene ex- 
l'ression and cell growth [26]. 
Whereas the extracellular signal-regulated protein kinase 
~aodule responds primarily to mitogenic agonists, two more 
~ ecently characterized kinase cascades are responsive to cellu- 
!~r stresses uch as interleukin 1, tumour necrosis factor cx, 
!,eat shock, UV light, osmotic shock and metabolic poisons. 
"hese novel kinases were termed stress-activated protein ki- 
Lase (SAPK, also termed c-Jun N -terminal kinase) and p38 
i:inase [22,26]. Activation of SAPKs and p38 kinase is a dou- 
,le-edged sword in that these kinases may trigger repair pro- 
esses following cellular injury thus acting in a reparative 
,nanner or, alternatively, they may initiate the programm of 
e l l  death to remove unwanted or irreversibly damaged cells 
22]. Recently it has been suggested that a dynamic equilib- 
ium between the extracellular signal-regulated protein ki- 
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Fig. 3. Effects of N-acetylcysteiue and genistein on SAPK activity in 
glomerular endothelial nd mesangial cells. Quiescent endothelial or 
nesangial cells were treated with MAHMA-NONOate (1 mM, NO) 
n the absence or presence of the indicated concentrations of N-ace- 
~ylcysteine (NAC) or genistein (G) for 60 rain (endothelial cells) or 
~0 min (mesangial cells). Thereafter, cells were harvested and SAPK 
tctivity was measured as described in Section 2. Results are 
means + S.D. of three independent 3 experiments. 
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Fig. 4. MAHMA-NONOate induced apoptosis in gomerular en- 
dothelial and mesangial cells. Mesangial cells or endothelial cells 
were incubated with vehicle (Co) or MAHMA-NONOate (NO, 1 
mM) in the absence or presence of N-acetylcyteine (NAC, 20 raM) 
or genistein (G, 50 [aM) for 24 h. Cytosolic oligonucleosome-bound 
DNA was quantitated by an ELISA kit, DNA fragmentation is in- 
dicated as % of untreated control cells. Data are means+S.D, of 
three independent experiments. 
nase pathway and the SAPK/p38 kinase pathway determines 
whether cells survive or undergo programmed cell death [15]. 
A shift in this dynamic balance by either activation of SAPK/ 
p38 kinase activity or inhibition of the extracellular signal 
regulated protein kinase pathway may cause an increased 
rate of cell death. NO is also a double-edged sword. Synthe- 
sized in appropriate amounts it exerts important physiological 
functions. However, when produced in excessive amounts by 
the inducible NO synthase, it may contribute to the pathogen- 
esis of a number of severe diseases, including circulatory 
shock and inflammation [11,27]. The exact mechanisms by 
which NO exerts its damaging effects are not yet fully under- 
stood. Inhibition of iron-sulfur proteins like aconitase, com- 
plexes I and II of the mitochondria respiratory chain, and 
ribonucleotide reductase or NAD(H)-dependent covalent 
modification of glyceraldehyde-3-phosphate dehydrogenase 
[28,29] and DNA damage as well as strand breaks [30-32] 
may contribute to the cytotoxic properties of NO. NO has 
recently been reported to initiate programmed cell death in 
a variety of cell types [33-40] including glomerular mesangial, 
endothelial and epithelial cells [12]. We no,h report that NO 
activates the SAPK pathway in glomerular mesangial and 
endothelial cells thus providing a link to the subsequent in- 
itiation of apoptosis in these cells (Fig. 4 and [12]). Our ob- 
servations confirm and extend the very recent report of Lo et 
al. [41] who showed that reactive oxygen species mediate cy- 
tokine activation of SAPK in bovine chondrocytes. The exact 
mechanism by which NO causes SAPK activation has yet to 
be elucidated. Whether NO directly activates one of the at 
least 10 isoforms of SAPK known today [42] or interacts 
with the upstream regulators like SAPK kinase, p21-activated 
kinase (PAK) or the Ras-related small GTP-binding proteins 
(cdc 42, Rac 1) [43] are some pressing questions that immedi- 
ately arise. Identification of direct targets of NO and signal- 
ling pathway triggered by NO will offer new approaches for 
therapeutic intervention in acute and chronic inflammatory 
diseases and tumour development. 
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